title: Management of diabetes in pregnancy.
abstract: The link between diabetes and poor pregnancy outcomes is well established. As in the non-pregnant population, pregnant women with diabetes can experience profound effects on multiple maternal organ systems. In the fetus, morbidities arising from exposure to diabetes in utero include not only increased congenital anomalies, fetal overgrowth, and stillbirth, but metabolic abnormalities that appear to carry on into early life, adolescence, and beyond. This article emphasizes the newest guidelines for diabetes screening in pregnancy while reviewing their potential impact on maternal and neonatal complications that arise in the setting of hyperglycemia in pregnancy.
authors.affiliation: Reproductive Medicine Department, University of California San Diego, 200 West Arbor Drive, San Diego, CA, USA.
authors.forename: Jerasimos
authors.initials: J
authors.lastname: Ballas
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Moore
authors.forename: Gladys A
authors.initials: GA
authors.lastname: Ramos
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology; D016640:Diabetes, Gestational / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008403:Mass Screening; D008687:Metformin / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011256:Pregnancy Outcome; D011254:Pregnancy in Diabetics / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: C417231:Glucovance; D007004:Hypoglycemic Agents; D008687:Metformin; D005905:Glyburide